Pharma channel feed

GSK, Pfiz­er head in­to patent du­el in high-stakes RSV vac­cine war

Last year
Law

Medicare may save $1.8B from four drugs in first year of price ne­go­ti­a­tions, re­search finds

Last year

FDA ap­proves Tai­ho's Lon­surf with be­va­cizum­ab for metasta­t­ic col­orec­tal can­cer

Last year
FDA+

BeiGene's BTK in­hibitor brings in $308M, dri­ves Q2 earn­ings with 46% in­crease from Q1

Last year

Third in line: Ed­i­tas says it may part­ner up on com­mer­cial­iza­tion of sick­le cell gene ther­a­py

Last year
Cell/Gene Tx

Te­va sees rev­enue in­creas­es in Q2 as it con­tin­ues its ‘piv­ot to growth’ dri­ve

Last year
Manufacturing

Mar­tin Shkre­li's old com­pa­nies se­cure $650,000 deal to sell Dara­prim amid bank­rupt­cy

Last year
Deals

Pro­QR finds eye dis­ease part­ner in Eu­rope, hands off two late-stage can­di­dates

Last year
Deals

Com­mon can­cer drug man­u­fac­tur­er warned by the FDA over da­ta in In­dia

Last year
FDA+
Manufacturing

Ab­b­Vie, Lund­beck ask FDA to re­vise draft guid­ance on mi­graine drugs

Last year
FDA+

Hen­ri­et­ta Lack­s' fam­i­ly set­tles lit­i­ga­tion with Ther­mo Fish­er for undis­closed amount over im­mor­tal cells

Last year

Hu­mi­ra and Ste­lara con­tin­ue to lead spe­cial­ty drug spend­ing, but new­er drugs like Keytru­da, Skyrizi are clos­ing in — re­port

Last year
Marketing

Can the Bar­bie movie's spot­light on women’s is­sues spill over to phar­ma mar­ket­ing and health­care? Agency says yes

Last year
Marketing

Mar­ket­ingRx roundup: Mil­len­ni­als warm up to phar­ma ads; Astel­las, Seagen add to blad­der can­cer cam­paign

Last year
Marketing

With Covid rev­enues falling, Pfiz­er lays out growth plans and pos­si­ble cost cuts

Last year

Bio­Marin touts Vox­zo­go sales bump in Q2 re­sults, notes 'tem­porar­i­ly tight sup­ply'

Last year
Manufacturing

Up­dat­ed: Mer­ck Q2 earn­ings pro­pelled by Keytru­da, Gar­dasil sales, but ex­pects 's­low­er' growth for HPV vac­cine

Last year

Bris­tol My­ers, As­traZeneca strike $510M set­tle­ment on PD-L1, CT­LA-4 patent law­suits

Last year
Law

FDA looks to work with more out­side agen­cies for in­spec­tions as it en­ters in­to an agree­ment for in­spec­tions with Switzer­land

Last year
FDA+
Manufacturing

US gov­ern­ment OK with com­bin­ing brief­ing sched­ule from Bris­tol My­ers, J&J in IRA fight

Last year
Law

Vi­a­tris launch­es gener­ic for As­traZeneca's asth­ma and COPD drug Sym­bi­cort

Last year

A deal? An as­set sale? A launch? Every­one is watch­ing next moves for Roivant, Bridge­Bio

Last year
Deals

Phar­ma gi­ants tout AI tools as high pri­or­i­ty in half-year earn­ings re­ports

Last year
AI

Re­pub­li­cans share draft bill to ad­dress drug short­ages

Last year
FDA+
First page Previous page 111112113114115116117 Next page Last page
A service from the Financial Times